Literature DB >> 33234878

Spindle-cell (Sarcomatoid) Variant of Cutaneous Anaplastic Large-cell Lymphoma (C-ALCL): An Unusual Mimicker of Cutaneous Malignant Mesenchymal Tumors-A Series of 11 Cases.

Alejandro A Gru1, Govind Bhagat2, Antonio Subtil3, Shyam S Raghavan1, Melissa Pulitzer4, Catherine Chung5, Martin Sangueza6, Jose A Plaza5.   

Abstract

Cutaneous anaplastic large-cell lymphoma (C-ALCL) represents one of the entities within the group of CD30-positive lymphoproliferative disorders of the skin. Most cases are ALK-negative, though isolated cases of ALK-positive C-ALCL have also been reported. By definition, the diagnosis of C-ALCL requires the expression of CD30 in >75% of the cells. Histopathologically, C-ALCL shows a dermal-based nodular and circumscribed proliferation of large pleomorphic cells with vesicular nuclei, prominent nucleoli, and eosinophilic cytoplasm, including hallmark cells. Since 1990, isolated case reports of a so-called "sarcomatoid" variant have been published in the literature. Herein, we present a series of 11 cases of spindle (sarcomatoid) C-ALCL, with comprehensive histopathologic, immunophenotypic, and molecular data. Spindle C-ALCL represents a potential mimicker of malignant mesenchymal or hematopoietic tumors in the skin and should always be considered in the differential diagnosis when assessing cutaneous pleomorphic spindle cell neoplasms.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33234878      PMCID: PMC9555340          DOI: 10.1097/PAS.0000000000001623

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.298


  43 in total

1.  Atypical fibroxanthoma with lymphomatoid reaction.

Authors:  Rui Zheng; Linglei Ma; Christopher K Bichakjian; Lori Lowe; Douglas R Fullen
Journal:  J Cutan Pathol       Date:  2010-10-05       Impact factor: 1.587

2.  Cutaneous Spindle-Cell B-Cell Lymphomas: Most are Neoplasms of Follicular Center Cell Origin.

Authors:  Yann Charli-Joseph; Lorenzo Cerroni; Philip E LeBoit
Journal:  Am J Surg Pathol       Date:  2015-06       Impact factor: 6.394

3.  Myxoid variant of primary cutaneous anaplastic large cell lymphoma: First 2 cases.

Authors:  Angel Fernandez-Flores; Ariana Eginli; David S Cassarino
Journal:  J Cutan Pathol       Date:  2017-07-18       Impact factor: 1.587

Review 4.  Pyogenic variant of primary cutaneous anaplastic large-cell lymphoma: a lymphoproliferative disorder with a predilection for the immunocompromized and the young.

Authors:  John A Papalas; David Van Mater; Endi Wang
Journal:  Am J Dermatopathol       Date:  2010-12       Impact factor: 1.533

5.  Infantile NTRK-associated Mesenchymal Tumors.

Authors:  Jessica L Davis; Christina M Lockwood; Catherine M Albert; Karen Tsuchiya; Douglas S Hawkins; Erin R Rudzinski
Journal:  Pediatr Dev Pathol       Date:  2017-07-06

6.  Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial.

Authors:  H Miles Prince; Youn H Kim; Steven M Horwitz; Reinhard Dummer; Julia Scarisbrick; Pietro Quaglino; Pier Luigi Zinzani; Pascal Wolter; Jose A Sanches; Pablo L Ortiz-Romero; Oleg E Akilov; Larisa Geskin; Judith Trotman; Kerry Taylor; Stephane Dalle; Michael Weichenthal; Jan Walewski; David Fisher; Brigitte Dréno; Rudolf Stadler; Tatyana Feldman; Timothy M Kuzel; Yinghui Wang; Maria Corinna Palanca-Wessels; Erin Zagadailov; William L Trepicchio; Wenwen Zhang; Hui-Min Lin; Yi Liu; Dirk Huebner; Meredith Little; Sean Whittaker; Madeleine Duvic
Journal:  Lancet       Date:  2017-06-07       Impact factor: 79.321

7.  Pseudolymphomatous Atypical Fibroxanthoma.

Authors:  Rubén Garcia Castro; Alex Viñolas-Cuadros; David Moyano-Bueno; Alberto Conde-Ferreiros; Esther Cardeñoso; Angel Santos-Briz
Journal:  Am J Dermatopathol       Date:  2020-12       Impact factor: 1.533

8.  Tumours classified as "malignant histiocytosis" in children are T-cell neoplasms.

Authors:  K Ornvold; H Carstensen; J Junge; A Gyhrs; E Ralfkiaer
Journal:  APMIS       Date:  1992-06       Impact factor: 3.205

9.  Clinical, Histologic, and Molecular Characteristics of Anaplastic Lymphoma Kinase-positive Primary Cutaneous Anaplastic Large Cell Lymphoma.

Authors:  Rutger C Melchers; Rein Willemze; Merel van de Loo; Remco van Doorn; Patty M Jansen; Arjen H G Cleven; Nienke Solleveld; Marcel W Bekkenk; Marloes S van Kester; Gillis F H Diercks; Maarten H Vermeer; Koen D Quint
Journal:  Am J Surg Pathol       Date:  2020-06       Impact factor: 6.394

10.  Combined Modality Treatment With Brentuximab Vedotin and Radiation Therapy for Primary Cutaneous Anaplastic Large Cell Lymphoma: A Case Report.

Authors:  Erin G Floyd; Timothy F Burns; Konstantinos Linos; Robert E LeBlanc; Joi B Carter; Lesley A Jarvis; Frederick Lansigan
Journal:  J Hematol (Brossard)       Date:  2019-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.